
People who live past 110 carry blood loaded with rare “killer” immune cells that seem built to hunt down cancer and other dangerous cells.
Story Snapshot
- Scientists in Japan found supercentenarians, people over 110, have unusually high levels of cytotoxic CD4 T cells in their blood.
- These cells normally act as “helpers” in the immune system but shift into cell-killing mode in the oldest people studied.
- Genetic testing showed these killer cells multiplied by cloning themselves after repeatedly fighting off the same threats.
- Newer research suggests this cell buildup starts around age 100 and keeps growing as people age further.
What Researchers Found In The Blood Of The Oldest People Alive
Scientists from the RIKEN Center for Integrative Medical Science and Keio University School of Medicine studied blood samples from supercentenarians, people who reached 110 years old. They used single-cell technology to look at thousands of individual immune cells at once. What stood out was a big jump in cytotoxic CD4 T cells, a rare immune cell type that can kill other cells directly.
Most CD4 T cells act like coaches. They call other immune cells into action instead of attacking threats themselves. But in supercentenarians, many of these cells switched roles entirely. They picked up killer instincts usually reserved for a different immune cell type altogether, based on the original 2019 study published in the Proceedings of the National Academy of Sciences.
How These Killer Cells Multiplied Inside The Body
Researchers sequenced the genetic receptors of these cells in two supercentenarians. They found the killer CD4 cells had built up their numbers through massive cloning. One single cell type made up more than half of all the killer CD4 cells in one person studied, pointing to repeated battles against the same target over many decades.
This kind of clonal buildup usually signals the immune system fighting off something specific, over and over, for years. Scientists believe repeated exposure to viruses or abnormal cells over a long lifetime may train these cells to specialize and multiply. Chosun reported that supercentenarians carried more than four times as many of these killer cells compared to younger elderly people.
Newer Research Shows The Pattern Starts Around Age 100
A follow-up study published in Cell Reports in 2026, led by some of the same researchers, tracked when this immune shift begins. They found cytotoxic CD4 T cells start expanding around age 100 and keep climbing as people age past that milestone. The team called this pattern a sign of “adaptive expansion” rather than simple immune decline.
Science Daily summarized the newer findings by noting these killer cells grew more common with age and often formed large clusters of nearly identical cells. This supported the idea that the immune system kept responding to the same threats repeatedly over a lifetime, refining its defenses rather than wearing out.
Why This Matters Beyond A Small Group Of Super Agers
Reviews of the research caution that these killer CD4 cells are not automatically good news in every case. Scientific reviews describe them as playing both protective and harmful roles depending on the situation, since the same cell type shows up in some disease conditions too. That nuance matters for anyone hoping this points to a simple anti-aging fix.
Still, the discovery adds a serious data point to how scientists think about human longevity. Instead of picturing aging as a slow immune collapse, researchers now see evidence that some parts of the immune system may actually sharpen with age in the rare people who live the longest. Scientific American highlighted that the same research team later found these cells keep cloning themselves well past age 100, suggesting continued activity rather than fading immune strength.
For most Americans, the practical takeaway is not a treatment or a pill. It is proof that the human body, under the right conditions, can maintain a sharp, targeted defense system deep into extreme old age. Readers who value personal responsibility and resilience over quick fixes may find this a reminder that a lifetime of surviving challenges, biological and otherwise, can build lasting strength rather than simply wearing a person down.
Sources:
sciencedaily.com, pnas.org, riken.jp, pubmed.ncbi.nlm.nih.gov, academic.oup.com, pmc.ncbi.nlm.nih.gov, scientificamerican.com













